Rexam invests $20M in French plant; Julphar opens first plant in Africa;

@EricPFierce: Would your plant receive an A or an F under FDA Woodcock's suggestion of letter grades for quality? More | Follow @EricPFierce

> Rexam is investing $20.3 million in a plant in France to meet growing demand for insulin products from Eli Lilly ($LLY). Story

> Sigma-Aldrich ($SIAL) said fourth-quarter earnings rose 7.4% as acquisitions added to revenue. Release

> The International Conference on Harmonisation has issued draft guidance for controlling carcinogenic risk in products made from genotoxic or carcinogenic starting materials. Story

> United Arab Emirates-based pharmaceuticals manufacturer Julphar has opened a manufacturing facility in Africa in Ethiopia, with a local partner. Story

> MeadWestvaco said it is investing $7.5 million in a packaging plant in Hemer, Germany. Release

And Finally... What are the options for drugmakers when their contract manufacturer has to close a plant because of FDA GMP issues? More